Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining - PubMed (original) (raw)

. 1973 Jun 1;243(5405):290-3.

doi: 10.1038/243290a0.

• PMID: 4126434
• DOI: 10.1038/243290a0

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

J D Rowley. Nature. 1973.

No abstract available

PubMed Disclaimer

Similar articles

• Heterogeneity of Ph1 in chronic myeloid leukaemia.
  Mitelman F. Mitelman F. Hereditas. 1974;76(2):315-6. doi: 10.1111/j.1601-5223.1974.tb01347.x. Hereditas. 1974. PMID: 4135826 No abstract available.
• Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques.
  Hossfeld DK. Hossfeld DK. Humangenetik. 1974 Jul 15;23(2):111-8. doi: 10.1007/BF00282208. Humangenetik. 1974. PMID: 4136793 No abstract available.
• Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia.
  Rowley JD. Rowley JD. J Med Genet. 1974 Jun;11(2):166-70. doi: 10.1136/jmg.11.2.166. J Med Genet. 1974. PMID: 4135401 Free PMC article.
• The Philadelphia chromosome.
  Baserga A, Castoldi GL. Baserga A, et al. Biomedicine. 1973 Mar;18(2):89-94. Biomedicine. 1973. PMID: 4125985 Review. No abstract available.
• Ph1-positive leukaemia, including chronic myelogenous leukaemia.
  Rowley JD. Rowley JD. Clin Haematol. 1980 Feb;9(1):55-86. Clin Haematol. 1980. PMID: 6245823 Review. No abstract available.

Cited by

• How Have Massively Parallel Sequencing Technologies Furthered Our Understanding of Oncogenesis and Cancer Progression?
  Onuselogu DA, Benz S, Mitra S. Onuselogu DA, et al. Methods Mol Biol. 2025;2866:265-286. doi: 10.1007/978-1-0716-4192-7_15. Methods Mol Biol. 2025. PMID: 39546208 Review.
• Copy number variation heterogeneity reveals biological inconsistency in hierarchical cancer classifications.
  Yang Z, Carrio-Cordo P, Baudis M. Yang Z, et al. Mol Cytogenet. 2024 Nov 6;17(1):26. doi: 10.1186/s13039-024-00692-2. Mol Cytogenet. 2024. PMID: 39506842 Free PMC article.
• Predicting drug resistance.
  Arellano NS, Elf SE. Arellano NS, et al. Elife. 2024 Nov 6;13:e103775. doi: 10.7554/eLife.103775. Elife. 2024. PMID: 39503728 Free PMC article.
• Peculiar _k_-mer Spectra Are Correlated with 3D Contact Frequencies and Breakpoint Regions in the Human Genome.
  Hikmat WM, Sievers A, Hausmann M, Hildenbrand G. Hikmat WM, et al. Genes (Basel). 2024 Sep 25;15(10):1247. doi: 10.3390/genes15101247. Genes (Basel). 2024. PMID: 39457371 Free PMC article.
• Bilateral visual loss as the initial presentation of chronic myeloid leukemia: a case report.
  Saadeldine SM, Alammouri YM. Saadeldine SM, et al. Ann Med Surg (Lond). 2024 Sep 12;86(10):6335-6339. doi: 10.1097/MS9.0000000000002570. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359756 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database